100 related articles for article (PubMed ID: 21503576)
1. Sesamin induces autophagy in colon cancer cells by reducing tyrosine phosphorylation of EphA1 and EphB2.
Tanabe H; Kuribayashi K; Tsuji N; Tanaka M; Kobayashi D; Watanabe N
Int J Oncol; 2011 Jul; 39(1):33-40. PubMed ID: 21503576
[TBL] [Abstract][Full Text] [Related]
2. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth.
Chaudhari A; Mahfouz M; Fialho AM; Yamada T; Granja AT; Zhu Y; Hashimoto W; Schlarb-Ridley B; Cho W; Das Gupta TK; Chakrabarty AM
Biochemistry; 2007 Feb; 46(7):1799-810. PubMed ID: 17249693
[TBL] [Abstract][Full Text] [Related]
3. Role of the EphB2 receptor in autophagy, apoptosis and invasion in human breast cancer cells.
Chukkapalli S; Amessou M; Dilly AK; Dekhil H; Zhao J; Liu Q; Bejna A; Thomas RD; Bandyopadhyay S; Bismar TA; Neill D; Azoulay L; Batist G; Kandouz M
Exp Cell Res; 2014 Jan; 320(2):233-46. PubMed ID: 24211352
[TBL] [Abstract][Full Text] [Related]
4. Sesamin induces ER stress-mediated apoptosis and activates autophagy in cervical cancer cells.
Dou H; Yang S; Hu Y; Xu D; Liu L; Li X
Life Sci; 2018 May; 200():87-93. PubMed ID: 29505783
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of inactivation of the receptor tyrosine kinase EPHB2 in colorectal tumors.
Alazzouzi H; Davalos V; Kokko A; Domingo E; Woerner SM; Wilson AJ; Konrad L; Laiho P; Espín E; Armengol M; Imai K; Yamamoto H; Mariadason JM; Gebert JF; Aaltonen LA; Schwartz S; Arango D
Cancer Res; 2005 Nov; 65(22):10170-3. PubMed ID: 16288001
[TBL] [Abstract][Full Text] [Related]
6. Sodium 5,6-benzylidene-L-ascorbate induces oxidative stress, autophagy, and growth arrest in human colon cancer HT-29 cells.
Cheung FW; Che CT; Sakagami H; Kochi M; Liu WK
J Cell Biochem; 2010 Oct; 111(2):412-24. PubMed ID: 20503249
[TBL] [Abstract][Full Text] [Related]
7. Preferential induction of EphB4 over EphB2 and its implication in colorectal cancer progression.
Kumar SR; Scehnet JS; Ley EJ; Singh J; Krasnoperov V; Liu R; Manchanda PK; Ladner RD; Hawes D; Weaver FA; Beart RW; Singh G; Nguyen C; Kahn M; Gill PS
Cancer Res; 2009 May; 69(9):3736-45. PubMed ID: 19366806
[TBL] [Abstract][Full Text] [Related]
8. Sesamin attenuates intercellular cell adhesion molecule-1 expression in vitro in TNF-alpha-treated human aortic endothelial cells and in vivo in apolipoprotein-E-deficient mice.
Wu WH; Wang SH; Kuan II; Kao YS; Wu PJ; Liang CJ; Chien HF; Kao CH; Huang CJ; Chen YL
Mol Nutr Food Res; 2010 Sep; 54(9):1340-50. PubMed ID: 20306475
[TBL] [Abstract][Full Text] [Related]
9. Sesamin and episesamin induce apoptosis in human lymphoid leukemia Molt 4B cells.
Miyahara Y; Komiya T; Katsuzaki H; Imai K; Nakagawa M; Ishi Y; Hibasami H
Int J Mol Med; 2000 Jul; 6(1):43-6. PubMed ID: 10851264
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction.
Elowe S; Holland SJ; Kulkarni S; Pawson T
Mol Cell Biol; 2001 Nov; 21(21):7429-41. PubMed ID: 11585923
[TBL] [Abstract][Full Text] [Related]
11. The EphB2 tumor suppressor induces autophagic cell death via concomitant activation of the ERK1/2 and PI3K pathways.
Kandouz M; Haidara K; Zhao J; Brisson ML; Batist G
Cell Cycle; 2010 Jan; 9(2):398-407. PubMed ID: 20046096
[TBL] [Abstract][Full Text] [Related]
12. Promoted cancer growth by stimulating cell proliferation and decreasing apoptosis using a lentivirus-based EphB2 RNAi in pancreatic carcinoma CFPAC-1 cells.
Hua YQ; Ouyang HQ; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Liu LM
Biomed Pharmacother; 2011 Mar; 65(2):123-31. PubMed ID: 21292437
[TBL] [Abstract][Full Text] [Related]
13. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer.
Huusko P; Ponciano-Jackson D; Wolf M; Kiefer JA; Azorsa DO; Tuzmen S; Weaver D; Robbins C; Moses T; Allinen M; Hautaniemi S; Chen Y; Elkahloun A; Basik M; Bova GS; Bubendorf L; Lugli A; Sauter G; Schleutker J; Ozcelik H; Elowe S; Pawson T; Trent JM; Carpten JD; Kallioniemi OP; Mousses S
Nat Genet; 2004 Sep; 36(9):979-83. PubMed ID: 15300251
[TBL] [Abstract][Full Text] [Related]
14. c-Rel is a transcriptional repressor of EPHB2 in colorectal cancer.
Fu T; Li P; Wang H; He Y; Luo D; Zhang A; Tong W; Zhang L; Liu B; Hu C
J Pathol; 2009 Sep; 219(1):103-13. PubMed ID: 19621336
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive review on the anti-cancer properties and mechanisms of action of sesamin, a lignan in sesame seeds (Sesamum indicum).
Majdalawieh AF; Massri M; Nasrallah GK
Eur J Pharmacol; 2017 Nov; 815():512-521. PubMed ID: 29032105
[TBL] [Abstract][Full Text] [Related]
17. EphB2 expression across 138 human tumor types in a tissue microarray: high levels of expression in gastrointestinal cancers.
Lugli A; Spichtin H; Maurer R; Mirlacher M; Kiefer J; Huusko P; Azorsa D; Terracciano L; Sauter G; Kallioniemi OP; Mousses S; Tornillo L
Clin Cancer Res; 2005 Sep; 11(18):6450-8. PubMed ID: 16166419
[TBL] [Abstract][Full Text] [Related]
18. Sesamin promotes apoptosis and pyroptosis via autophagy to enhance antitumour effects on murine T-cell lymphoma.
Meng Z; Liu H; Zhang J; Zheng Z; Wang Z; Zhang L; Jia Z; Sui Y
J Pharmacol Sci; 2021 Nov; 147(3):260-270. PubMed ID: 34507635
[TBL] [Abstract][Full Text] [Related]
19. Juxtamembrane tyrosine residues couple the Eph family receptor EphB2/Nuk to specific SH2 domain proteins in neuronal cells.
Holland SJ; Gale NW; Gish GD; Roth RA; Songyang Z; Cantley LC; Henkemeyer M; Yancopoulos GD; Pawson T
EMBO J; 1997 Jul; 16(13):3877-88. PubMed ID: 9233798
[TBL] [Abstract][Full Text] [Related]
20. EphB2 is a prognostic factor in colorectal cancer.
Jubb AM; Zhong F; Bheddah S; Grabsch HI; Frantz GD; Mueller W; Kavi V; Quirke P; Polakis P; Koeppen H
Clin Cancer Res; 2005 Jul; 11(14):5181-7. PubMed ID: 16033834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
